Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Liver Diseases

Free Subscription Articles published in Semin Liver Dis Retrieve available abstracts of 72 articles: HTML format

Single Articles

September 2025
1. ISRAELSEN M, Trepo E, Krag A, Stender S, et al
   MetALD: Genetic Factors and Clinical Outcomes.
   Semin Liver Dis. 2025;45:269-282.
   PubMed     Abstract available
   
   
   
2. WANG R, Ma F, Yin D, Wang H, et al
   Intestinal Microbes, Metabolites, and Hormones in Alcohol-Associated Liver Disease.
   Semin Liver Dis. 2025;45:283-302.
   PubMed     Abstract available
   
   
   
3. MRAVEC B, Szantova M
   Liver Neurobiology: Regulation of Liver Functions by the Nervous System.
   Semin Liver Dis. 2025;45:420-437.
   PubMed     Abstract available
   
   
   
4. CAO P, Jaeschke H, Ni HM, Ding WX, et al
   The Ways to Die: Cell Death in Liver Pathophysiology.
   Semin Liver Dis. 2025;45:397-419.
   PubMed     Abstract available
   
   
   August 2025
5. BALOGUN O, Nejak-Bowen K
   Animal Models of Porphyria with Hepatic Involvement.
   Semin Liver Dis. 2025 Aug 21. doi: 10.1055/a-2677-6806.
   PubMed     Abstract available
   
   
   
6. HASSAN A, Tapper E
   Patient-centered treatment of cirrhosis.
   Semin Liver Dis. 2025 Aug 18. doi: 10.1055/a-2684-6289.
   PubMed     Abstract available
   
   
   June 2025
7. BEIER JI, Luo J, Vanderpuye CM, Brizendine P, et al
   Environmental Pollutants, Occupational Exposures, and Liver Disease.
   Semin Liver Dis. 2025;45:148-166.
   PubMed     Abstract available
   
   
   
8. GRATACOS-GINES J, Alvarado-Tapias E, Marti-Aguado D, Lopez-Pelayo H, et al
   Diagnosis and Management of Early Stages of ALD.
   Semin Liver Dis. 2025;45:195-209.
   PubMed     Abstract available
   
   
   
9. WASHINGTON AM, Kostallari E
   Extracellular Vesicles and Micro-RNAs in Liver Disease.
   Semin Liver Dis. 2025;45:167-179.
   PubMed     Abstract available
   
   
   
10. MARINO Z, Schilsky ML
    Wilson Disease: Novel Diagnostic and Therapeutic Approaches.
    Semin Liver Dis. 2025;45:221-235.
    PubMed     Abstract available
    
    
    
11. BARBERA A, White TM, Arora AK, Henry L, et al
    Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Semin Liver Dis. 2025;45:210-220.
    PubMed     Abstract available
    
    
    
12. TORRES S, Hardesty J, Barrios M, Garcia-Ruiz C, et al
    Mitochondria and Alcohol-Associated Liver Disease: Pathogenic Role and Target for Therapy.
    Semin Liver Dis. 2025;45:180-194.
    PubMed     Abstract available
    
    
    
13. SINGAL AK
    Preface (Introduction): Metabolic Liver Disease: A New Era in Hepatology.
    Semin Liver Dis. 2025;45:145-147.
    PubMed    
    
    
    May 2025
14. HUANG HYR, Schneider KM, Schneider C
    Big Data Analytics in Large Cohorts: Opportunities and Challenges for Research in Hepatology.
    Semin Liver Dis. 2025 May 21. doi: 10.1055/a-2599-3728.
    PubMed     Abstract available
    
    
    April 2025
15. JIAO H, Wang H, Li J, Yang Z, et al
    The Molecular Pathogenesis of Sarcopenia/Frailty in Cirrhosis.
    Semin Liver Dis. 2025 Apr 16. doi: 10.1055/a-2564-7551.
    PubMed     Abstract available
    
    
    
16. RAMIREZ-QUESADA W, Alvarado-Tapias E, Shalaby S, Hernandez-Gea V, et al
    Recompensation in Cirrhosis: Biomarkers and Strategies.
    Semin Liver Dis. 2025 Apr 3. doi: 10.1055/a-2542-9930.
    PubMed     Abstract available
    
    
    
17. SONG Y, Yang X, Yu C
    Understanding and Treating Hepatorenal Syndrome: Insights from Recent Research.
    Semin Liver Dis. 2025 Apr 1. doi: 10.1055/a-2570-3330.
    PubMed     Abstract available
    
    
    March 2025
18. PANT K, Peixoto E, Gradilone SA
    Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases.
    Semin Liver Dis. 2025 Mar 21. doi: 10.1055/a-2563-9791.
    PubMed     Abstract available
    
    
    
19. SEREROLS-VINAS L, Garcia-Vicien G, Ruiz-Blazquez P, Lee T, et al
    Hepatic stellate cells functional heterogeneity in liver cancer.
    Semin Liver Dis. 2025 Mar 5. doi: 10.1055/a-2551-0724.
    PubMed     Abstract available
    
    
    
20. LIU T, Zhang F, Feng Y, Han P, et al
    Alcohol-Metabolizing Enzymes, Liver Diseases and Cancer.
    Semin Liver Dis. 2025;45:99-113.
    PubMed     Abstract available
    
    
    
21. HILSCHER MB, Johnson JN
    Fontan-Associated Liver Disease.
    Semin Liver Dis. 2025;45:114-128.
    PubMed     Abstract available
    
    
    
22. POHL J, Aretakis D, Tacke F, Engelmann C, et al
    Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2025;45:52-65.
    PubMed     Abstract available
    
    
    
23. ABI-AAD SJ, Lovell M, Khalaf RT, Sokol RJ, et al
    Pathogenesis and Management of Intestinal Failure-Associated Liver Disease.
    Semin Liver Dis. 2025;45:66-80.
    PubMed     Abstract available
    
    
    
24. ZHANG JW, Zhang N, Lyu Y, Zhang XF, et al
    Influence of Sex in the Development of Liver Diseases.
    Semin Liver Dis. 2025;45:15-32.
    PubMed     Abstract available
    
    
    
25. WU Q, Yang D, Liu C, Xu T, et al
    Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury.
    Semin Liver Dis. 2025;45:81-98.
    PubMed     Abstract available
    
    
    
26. ANWAR AA, Jalan-Sakrikar N, Huebert RC
    LncRNAs, RNA Therapeutics, and Emerging Technologies in Liver Pathobiology.
    Semin Liver Dis. 2025;45:1-14.
    PubMed     Abstract available
    
    
    January 2025
27. PREMKUMAR M, Kajal K, Gupta P, Reddy R, et al
    Current Concepts in Fluid Resuscitation and Vasopressor Use in Cirrhosis.
    Semin Liver Dis. 2025 Jan 14. doi: 10.1055/a-2515-2783.
    PubMed     Abstract available
    
    
    November 2024
28. HUDSON D, Valentin Cortez FJ, Hurtado Diaz de Leon I, Malhi G, et al
    Advancements in MELD score and its impact in Hepatology.
    Semin Liver Dis. 2024 Nov 8. doi: 10.1055/a-2464-9543.
    PubMed     Abstract available
    
    
    
29. PRADO LG, Nagy LE
    Role of Complement in Liver Diseases.
    Semin Liver Dis. 2024;44:510-522.
    PubMed     Abstract available
    
    
    
30. POMPILI E, Iannone G, Carrello D, Zaccherini G, et al
    Managing Multiorgan Failure in Acute on Chronic Liver Failure.
    Semin Liver Dis. 2024;44:492-509.
    PubMed     Abstract available
    
    
    
31. SETHI N, Khokhar M, Mathur M, Batra Y, et al
    Therapeutic Potential of Nutraceuticals against Drug-Induced Liver Injury.
    Semin Liver Dis. 2024;44:430-456.
    PubMed     Abstract available
    
    
    
32. MAHER S, Rajapakse J, El-Omar E, Zekry A, et al
    Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Semin Liver Dis. 2024;44:457-473.
    PubMed     Abstract available
    
    
    
33. DE JONG YP
    Mice Engrafted with Human Liver Cells.
    Semin Liver Dis. 2024;44:405-415.
    PubMed     Abstract available
    
    
    October 2024
34. MEENA BL, Sarin SK
    Management of Portal vein Thrombosis in Cirrhosis.
    Semin Liver Dis. 2024 Oct 4. doi: 10.1055/s-0044-1791247.
    PubMed     Abstract available
    
    
    August 2024
35. ARTEEL GE
    Extracellular matrix and hepatic wound healing before fibrosis.
    Semin Liver Dis. 2024 Aug 27. doi: 10.1055/a-2404-7973.
    PubMed     Abstract available
    
    
    
36. BALLESTER MP, Durmazer EN, Qi T, Jalan R, et al
    The value of ammonia as a biomarker in patients with cirrhosis.
    Semin Liver Dis. 2024 Aug 2. doi: 10.1055/a-2378-8942.
    PubMed     Abstract available
    
    
    
37. ZHANG IW, Lurje I, Lurje G, Knosalla C, et al
    Combined Organ Transplantation in Patients with Advanced Liver Disease.
    Semin Liver Dis. 2024;44:369-382.
    PubMed     Abstract available
    
    
    
38. CHOI YJ, Kim Y, Hwang S
    Role of Neutrophils in the Development of Steatotic Liver Disease.
    Semin Liver Dis. 2024;44:300-318.
    PubMed     Abstract available
    
    
    
39. THAKRAL N, Desalegn H, Diaz LA, Cabrera D, et al
    A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD.
    Semin Liver Dis. 2024;44:273-286.
    PubMed     Abstract available
    
    
    
40. CHEN C, Feng D, Wang Y, Yao T, et al
    Necrotic Liver Lesion Resolution: Another Mode of Liver Regeneration.
    Semin Liver Dis. 2024;44:333-342.
    PubMed     Abstract available
    
    
    
41. KOTULKAR M, Paine-Cabrera D, Apte U
    Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer.
    Semin Liver Dis. 2024;44:383-393.
    PubMed     Abstract available
    
    
    
42. QIAN S, Wang X, Chen Y, Zai Q, et al
    Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets.
    Semin Liver Dis. 2024;44:319-332.
    PubMed     Abstract available
    
    
    July 2024
43. TINCOPA MA, Loomba R
    Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic-Dysfunction-Associated Steatohepatitis.
    Semin Liver Dis. 2024 Jul 9. doi: 10.1055/s-0044-1788277.
    PubMed     Abstract available
    
    
    May 2024
44. BALOGUN O, Nejak-Bowen K
    Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs.
    Semin Liver Dis. 2024 May 17. doi: 10.1055/s-0044-1787076.
    PubMed     Abstract available
    
    
    
45. MA J, Bjornsson ES, Chalasani N
    Hepatotoxicity of Antibiotics and Antifungals and Their Safe Use in Hepatic Impairment.
    Semin Liver Dis. 2024 May 13. doi: 10.1055/s-0044-1787062.
    PubMed     Abstract available
    
    
    
46. WERNER W, Kuzminskaya M, Lurje I, Tacke F, et al
    Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
    Semin Liver Dis. 2024;44:159-179.
    PubMed     Abstract available
    
    
    
47. FISCHER AM, Lechea N, Coxson HO
    This Is What Metabolic Dysfunction-Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol.
    Semin Liver Dis. 2024;44:226-238.
    PubMed     Abstract available
    
    
    
48. LI CC, Liu M, Lee HP, Wu W, et al
    Heterogeneity in Liver Cancer Immune Microenvironment: Emerging Single-Cell and Spatial Perspectives.
    Semin Liver Dis. 2024;44:133-146.
    PubMed     Abstract available
    
    
    
49. PHAM N, Benhammou JN
    Statins in Chronic Liver Disease: Review of the Literature and Future Role.
    Semin Liver Dis. 2024;44:191-208.
    PubMed     Abstract available
    
    
    
50. FUJIWARA N, Kimura G, Nakagawa H
    Emerging Roles of Spatial Transcriptomics in Liver Research.
    Semin Liver Dis. 2024;44:115-132.
    PubMed     Abstract available
    
    
    April 2024
51. SAVIANO A, Roehlen N, Baumert TF
    Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma.
    Semin Liver Dis. 2024 Apr 22. doi: 10.1055/s-0044-1785646.
    PubMed     Abstract available
    
    
    March 2024
52. KODAMA T, Takehara T
    Molecular genealogy of metabolic-associated hepatocellular carcinoma.
    Semin Liver Dis. 2024 Mar 18. doi: 10.1055/a-2289-2298.
    PubMed     Abstract available
    
    
    February 2024
53. ROMERO-GOMEZ M, Arab JP, Oliveira CP, Hernandez M, et al
    Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?
    Semin Liver Dis. 2024;44:69-78.
    PubMed     Abstract available
    
    
    
54. CANIVET CM, Boursier J, Loomba R
    New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice.
    Semin Liver Dis. 2024;44:35-42.
    PubMed     Abstract available
    
    
    
55. MOUZAKI M, Woo JG, Divanovic S
    Gestational and Developmental Contributors of Pediatric MASLD.
    Semin Liver Dis. 2024;44:43-53.
    PubMed     Abstract available
    
    
    
56. TUTUSAUS A, Morales A, Garcia de Frutos P, Mari M, et al
    GAS6/TAM Axis as Therapeutic Target in Liver Diseases.
    Semin Liver Dis. 2024;44:99-114.
    PubMed     Abstract available
    
    
    
57. BESSONE F, Hillotte GL, Ahumada N, Jaureguizahar F, et al
    UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis.
    Semin Liver Dis. 2024;44:1-22.
    PubMed     Abstract available
    
    
    
58. EL-KASSAS M, Awad A, Elbadry M, Arab JP, et al
    Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Semin Liver Dis. 2024;44:54-68.
    PubMed     Abstract available
    
    
    
59. BECH KT, Lindvig KP, Thiele M, Castera L, et al
    Algorithms for Early Detection of Silent Liver Fibrosis in the Primary Care Setting.
    Semin Liver Dis. 2024;44:23-34.
    PubMed     Abstract available
    
    
    
60. LIU H, Sethi V, Li X, Xiao Y, et al
    Corrigendum: Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future.
    Semin Liver Dis. 2024;44:e1-e3.
    PubMed    
    
    
    January 2024
61. LIU H, Sethi V, Li X, Xiao Y, et al
    Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future.
    Semin Liver Dis. 2024 Jan 11. doi: 10.1055/a-2242-7543.
    PubMed     Abstract available
    
    
    November 2023
62. BALOGUN O, Nejak-Bowen K
    The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease.
    Semin Liver Dis. 2023 Nov 16. doi: 10.1055/s-0043-1776760.
    PubMed     Abstract available
    
    
    
63. WILSON SR, Duncan AW
    The Ploidy State as a Determinant of Hepatocyte Proliferation.
    Semin Liver Dis. 2023 Nov 15. doi: 10.1055/a-2211-2144.
    PubMed     Abstract available
    
    
    
64. HAN X, Sun Q, Xu M, Zhu G, et al
    Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.
    Semin Liver Dis. 2023 Nov 6. doi: 10.1055/s-0043-1776127.
    PubMed     Abstract available
    
    
    
65. SAEIDINEJAD M, Elshabrawi A, Sriphoosanaphan S, Andreola F, et al
    Novel Therapeutic Approaches in Treatment of Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2023;43:429-445.
    PubMed     Abstract available
    
    
    
66. DUTTA RK, Jun J, Du K, Diehl AM, et al
    Hedgehog Signaling: Implications in Liver Pathophysiology.
    Semin Liver Dis. 2023;43:418-428.
    PubMed     Abstract available
    
    
    August 2023
67. PEKARSKA K, Parker R
    Alcohol-Related Liver Disease: Is There a Safe Alcohol Consumption Limit for Liver Disease?
    Semin Liver Dis. 2023;43:305-310.
    PubMed     Abstract available
    
    
    
68. RANJBARIAN T, Schnabl B
    Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease.
    Semin Liver Dis. 2023;43:311-322.
    PubMed     Abstract available
    
    
    
69. DESHMUKH K, Apte U
    The Role of Endoplasmic Reticulum Stress Response in Liver Regeneration.
    Semin Liver Dis. 2023;43:279-292.
    PubMed     Abstract available
    
    
    
70. MEADOWS V, Yang Z, Basaly V, Guo GL, et al
    FXR Friend-ChIPs in the Enterohepatic System.
    Semin Liver Dis. 2023;43:267-278.
    PubMed     Abstract available
    
    
    
71. COOPER SA, Kostallari E, Shah VH
    Angiocrine Signaling in Sinusoidal Health and Disease.
    Semin Liver Dis. 2023;43:245-257.
    PubMed     Abstract available
    
    
    
72. RUIZ M, Lacaille F, Schrader C, Pons M, et al
    Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency.
    Semin Liver Dis. 2023;43:258-266.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.